跳至主要内容
临床试验/NCT05379348
NCT05379348进行中(未招募)不适用

Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

AdventHealth Translational Research Institute1 个研究点 分布在 1 个国家目标入组 1,423 人开始时间: 2022年3月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,423
试验地点
1
主要终点
Quantify the proportion of individuals at least 65 years old with cognitive impairment

研究概览

简要总结

The purpose of this study is to investigate how we can detect Alzheimer's disease early by using an online memory test and a simple blood test. These new methods for early diagnosis could allow people to begin treatment sooner, with the potential to improve the lives of millions of people.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Quantify the proportion of individuals at least 65 years old with cognitive impairment

时间窗: Less than 6 months

次要结局

未报告次要终点

研究者

发起方
AdventHealth Translational Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验